•   
  •   

India India: The largest vaccine manufacturer Requests the end of the

12:30  17 april  2021
12:30  17 april  2021 Source:   rfi.fr

Coronavirus: The point on the pandemic in the world

 Coronavirus: The point on the pandemic in the world © provided by the point N Oua measures, new balance sheets and highlights: one point on the latest developments in the Pandemic of Covid-19 in the world. France : 10 million first doses France has exceeded the 10 million first injections Thursday, a symbolic bar but also far from total protection against the epidemic. Nevertheless, the COVID-19 continues to fill the resuscitation services: with 5,729 patients in total, the level approaches the peak of the first wave (7,000 in April 2020).

India aims to vaccinate 250 million "priority people" by the end of July. But experts say that the pace of vaccination has been slow and unless the drive is scaled up, the target could be missed. On Tuesday the government decided to give emergency approvals to vaccines already in use in other countries. What about Covishield? The Oxford-AstraZeneca vaccine is being manufactured locally by the Serum Institute of India , the world's largest vaccine manufacturer . It says it is producing more than 60 million doses a month. The vaccine is made from a weakened version of a common cold virus (known as an

The head of an Indian company contracted to make AstraZeneca Plc's COVID vaccine said it could deliver it to health care workers and elderly Indians by January as the country's caseload of infections crossed nine million on Friday. The Serum Institute of India , the world's largest vaccine manufacturer , has already manufactured millions of doses of the vaccine that is being developed in collaboration with Oxford University while results from late-stage trials are awaited.

Vaccins AstraZeneca au Serum Institute of India à Pune, le 21 janvier 2021. component embargo © AstraZeneca vaccines at the Serum Institute of India in Pune, January 21, 2021. The world's largest manufacturer's boss Vaccines addressed directly to US President Joe Biden on Twitter. At the head of Serum Institute of India, Adar Poonawalla asked her on Friday, April 16 to end an embargo on component exports, which delays dose production.

with our correspondent in Bangalore,

Côme Bastin

presented as the world's first vaccine producer, India does not remain less dependent on the importation of foreign products to manufacture them, in particular of US adjuvants. United.

It is therefore "on behalf of the vaccination industry", and the world combat against the coronavirus that Adar Poonawalla asked Joe Biden to remove the embargo on the export of commodities, via Twitter.

Coronavirus: The South African Variant could "cross" the Pfizer-Israeli study

 Coronavirus: The South African Variant could Health-Coronavirus-Israel-Study: Coronavirus: The South African variant could "cross" the Pfizer-Israeli study © Reuters / Amir Cohen Coronavirus: The South African variant could "cross" the Israeli Pfizer-study vaccine by Maayan Libell Jerusalem (Reuters) - The variant of the coronavirus identified for the first time in South Africa is capable of "crossing" in a Certain measure The Pfizer and Biontech vaccine, concludes an Israeli study published Saturday but which has not yet been reviewed by

The Serum Institute of India , the world’s largest vaccine manufacturer , has already manufactured millions of doses of the vaccine that is being developed in collaboration with Oxford University while results from late-stage trials are awaited. Britain-based AstraZeneca has signed several supply and manufacturing deals with companies and governments around the world. On Thursday, data published in the medical journal The Lancet showed that AstraZeneca’s vaccine produced a strong immune response in older adults, with researchers expecting to release late-stage trial results by Christmas.

The " vaccine maitri" (Hindi for vaccine friendship) initiative was announced by Prime Minister Narendra Modi days after India began its nationwide vaccination campaign in January. " India is deeply honored to be a long-trusted partner in meeting the healthcare needs of the global community," Modi said last month. " India is rolling out a national program, and they can take a bit of that to other countries," he said adding that India 's large production capacity makes the initiative possible. "Over the last four decades, India has become a major manufacturer of pharmaceuticals, generic drugs, and vaccines .

The American administration has for the moment not reacted to the message that illustrates the pressure on vaccine producers, India in mind. Confronted with a second wave, the country decided to stop its exports to vaccinate its population

. 200 million doses for COVAX But last week already, the boss of Serum Institute of India indicated that his production was

"live"

. He declared that the American embargo on the components was going to "prohibit vaccines". World's leading producer, the Serum Institute manufactures the Astrazeneca vaccine, massively used in India. It must also provide 200 million doses under the

COVAX device,

to distribute the vaccine to poor countries. But India has for the moment administered only 117 million doses to its citizens. to read also:

Anti-Covid vaccines: the Serum Institute of India, a success in trompe-l'oeil

United States: Sanofi partners with moderna to produce up to 200 million .
vaccine doses © Mike Segar, Reuters A bottle of the Moderna vaccine against Cvid-19, photographed in New York, January 29 2021. The French laboratory Sanofi announced Monday that it would produce in the United States up to 200 million doses of the American vaccine against CVIV-19, "to satisfy global demand". Up to 200 million doses of the American Biotech Vaccine Moderna will be produced by the French Sanofi laboratory in the United States.

usr: 2
This is interesting!